PRPF18 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.788600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.832200E-01
Normal-vs-Stage2
2.565400E-01
Normal-vs-Stage3
2.531000E-01
Normal-vs-Stage4
9.381800E-01
Stage1-vs-Stage2
3.595600E-01
Stage1-vs-Stage3
2.496800E-01
Stage1-vs-Stage4
7.226600E-01
Stage2-vs-Stage3
4.295800E-01
Stage2-vs-Stage4
2.366800E-01
Stage3-vs-Stage4
2.229400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.848800E-01
Normal-vs-AfricanAmerican
3.329000E-01
Normal-vs-Asian
3.168800E-01
Caucasian-vs-AfricanAmerican
6.951600E-01
Caucasian-vs-Asian
6.956400E-01
AfricanAmerican-vs-Asian
4.648000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.622000E-01
Normal-vs-Female
3.105600E-01
Male-vs-Female
9.809000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.498600E-01
Normal-vs-Age(41-60Yrs)
3.568800E-01
Normal-vs-Age(61-80Yrs)
2.617000E-01
Normal-vs-Age(81-100Yrs)
2.050000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.842200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.017000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.878000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.616390E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.920600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.903200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.649200E-01
Normal-vs-Daily Drinker
2.891200E-01
Normal-vs-Weekly Drinker
3.680000E-01
Normal-vs-Occasional Drinker
6.704400E-01
Normal-vs-Social Drinker
1.691840E-01
Non Drinker-vs-Daily Drinker
9.603200E-01
Non Drinker-vs-Weekly Drinker
8.857600E-01
Non Drinker-vs-Occasional Drinker
2.419800E-01
Non Drinker-vs-Social Drinker
5.913000E-01
Daily Drinker-vs-Weekly Drinker
9.240200E-01
Daily Drinker-vs-Occasional Drinker
2.959000E-01
Daily Drinker-vs-Social Drinker
5.820200E-01
Weekly Drinker-vs-Occasional Drinker
4.209400E-01
Weekly Drinker-vs-Social Drinker
5.705200E-01
Occasional Drinker-vs-Social Drinker
1.523590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.047900E-02
Normal-vs-Grade 2
5.202900E-04
Normal-vs-Grade 3
1.599040E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.507900E-02
Grade 1-vs-Grade 3
2.194800E-01
Grade 1-vs-Grade 4
6.047900E-02
Grade 2-vs-Grade 3
5.381600E-01
Grade 2-vs-Grade 4
5.202900E-04
Grade 3-vs-Grade 4
1.599040E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.625800E-01
Normal-vs-NonDiabetic
2.507600E-01
Diabetic-vs-NonDiabetic
8.577600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.517200E-01
Normal-vs-NoPancreatitis
2.699800E-01
Pancreatitis-vs-NoPancreatitis
9.707400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.401400E-01
Normal-vs-N1
2.739200E-01
N0-vs-N1
7.076400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.547200E-01
Normal-vs-TP53-NonMutant
3.600400E-01
TP53-Mutant-vs-TP53-NonMutant
1.642410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
